CLIA solution - Demonstration of the power of synergy

We look for ways to provide more reliable diagnostics

We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.

Our strategy is anchored by three key projects – CLIA, MBA, and NGS – focusing our innovation and delivery across next-generation sequencing, chemiluminescent immunoassays, and Microblot-Array. By combining scientific excellence, strong innovation capacity, and a presence in more than 100 markets worldwide, we deliver solutions that advance laboratory practice and patient care, making us one of the key players in clinical diagnostics.

Mikrogen, partner of fully automated CLIA solution from BioVendor Group.

The BioVendor Group and Mikrogen have joined forces to bring harmonized CLIA portfolio of assays developed for the cutting-edge analyzer KleeYa® from Diatron.

Mikrogen is a global provider of system solutions for medical laboratory diagnostics. Developed and produced CLIA assays by Mikrogen extend diagnostic possibilities in the clinical area of Infectious diseases as well as in the area of neurodegenerative diseases. The strengths of BioVendor Group and Mikrogen opens up new opportunities for better diagnostics and more effective therapies.